Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVITRA: Envarsus vs Immediate Release Tacrolimus in Renal Allograft Failure
NCT03689075Phase 4Terminated
- Sponsor
- Imperial College Healthcare NHS Trust
- Start
- Nov 2018
- Primary completion
- Jun 2024
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in Allosensitization, sponsored by Imperial College Healthcare NHS Trust. Started Nov 2018; status: terminated.
02
Drugs
tacrolimus
03
Conditions
Allosensitization
Beyond the preview
Go deeper on NCT03689075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03689075.